A systematic review and meta-analysis of randomized controlled trials comparing intraoperative red blood cell transfusion strategies.
Lenet T, Baker L, Park L, Vered M, Zahrai A, Shorr R et al.
Ann Surg 2022; 275: 456-466.
Fourteen trials including 8641 procedures were studied. A restrictive blood transfusion policy did reduce the volume of blood transfused without increasing postoperative morbidity. Two of the trials did show adverse composite outcomes for restrictive transfusion.
Comment: The result isn’t definitive, but further evidence that restrictive transfusion is generally not harmful.
2 May 2022
Read paperAcademy
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
